Salih Ökten

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Turkish journal of chemistry

Archiv der Pharmazie

Journal of biochemical and molecular toxicology

Medical oncology (Northwood, London, England)

Kırıkkale University

Gaziosmanpasa Universitesi Fen bilimleri Enstitüsü (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kırıkkale University May 25 2020

Turkey

Assoc. Prof. Dr :: Science Education

Kirikkale Universitesi Feb 23 2011 - May 25 2020

Turkey

Assist. Prof. Dr. :: Primary Education

Education History

Gaziosmanpasa Universitesi Fen bilimleri Enstitüsü Feb 15 2004 - Aug 23 2009

Turkey

PHD :: Chemistry

Yuzuncu Yil Universitesi Fen Bilimleri Enstitüsü Feb 10 1999 - Jan 12 2002

Turkey

MSC :: Chemistry

Middle East Technical University Aug 10 1993 - Jan 19 1998

Turkey

BSC :: Chemistry Education

Publications

Raşit Fikret Yilmaz, Sultan Erkan, Salih Ökten, Ahmet Tutar, Ertan Şahin
Bromination and conversion of tetrahydro-1H-indene to bisoxirane with a new approach: synthesis, structural characterization by spectroscopic and theoretical methods, and biological analysis supported by DFT and docking. Turkish journal of chemistry 47 (6) (2023)
Raşit Fikret Yilmaz, Sultan Erkan, Salih Ökten, Ahmet Tutar, Ertan Şahin
Bromination and conversion of tetrahydro-1H-indene to bisoxirane with a new approach: synthesis, structural characterization by spectroscopic and theoretical methods, and biological analysis supported by DFT and docking. Turkish journal of chemistry 47 (6) (2023)
Tuğba Kul Köprülü, Salih Ökten, Vildan Enisoğlu Atalay, Şaban Tekİn, Osman Çakmak
Biological activity and molecular docking studies of some new quinolines as potent anticancer agents. Medical oncology (Northwood, London, England) 38 (7) (2021)
Salih Ökten, Ali Aydin, Ümit M Kocyigit, Osman Çakmak, Sultan Erkan, Cenk A Andac, Parham Taslimi, İlhami Gulçin
Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors. Archiv der Pharmazie 353 (9) (2020)
Evrencan Özcan, Salih Ökten, Tamer Eren
Decision making for promising quinoline-based anticancer agents through combined methodology. Journal of biochemical and molecular toxicology (2020)
Makbule Ekiz, Ahmet Tutar, Salih Ökten, Burcu Bütün, Ümit M Kocyigit, Parham Taslimi, Gülaçtı Topçu
Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors. Archiv der Pharmazie 351 (9) (2018)
Tuğba Kul Köprülü, Salih Ökten, Şaban Tekİn, Osman Çakmak
Biological evaluation of some quinoline derivatives with different functional groups as anticancer agents. Journal of biochemical and molecular toxicology 33 (3) (2018)

Salih Ökten.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Salih Ökten